|
GB0305929D0
(en)
*
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
US7521457B2
(en)
*
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
TW200804364A
(en)
*
|
2006-02-22 |
2008-01-16 |
Boehringer Ingelheim Int |
New compounds
|
|
WO2007115999A1
(en)
*
|
2006-04-10 |
2007-10-18 |
Boehringer Ingelheim International Gmbh |
2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
|
|
PE20120006A1
(es)
*
|
2006-05-15 |
2012-02-02 |
Boehringer Ingelheim Int |
Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
|
|
DE102006039003A1
(de)
|
2006-08-19 |
2008-02-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Verbindungen
|
|
JP2010505961A
(ja)
*
|
2006-10-09 |
2010-02-25 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
BRPI0719883A2
(pt)
*
|
2006-10-09 |
2015-05-05 |
Takeda Pharmaceutical |
Inibidores de quinase
|
|
ES2633318T3
(es)
|
2006-10-23 |
2017-09-20 |
Cephalon, Inc. |
Derivados bicíclicos fusionados de 2,4-diaminopirimidina como inhibidores de ALK y c-Met
|
|
DE102007010801A1
(de)
|
2007-03-02 |
2008-09-04 |
Bayer Cropscience Ag |
Diaminopyrimidine als Fungizide
|
|
DK2146779T3
(en)
*
|
2007-04-18 |
2016-11-28 |
Pfizer Prod Inc |
Sulfonylamid derivatives to treat abnormal cell growth.
|
|
EA015574B1
(ru)
*
|
2007-05-16 |
2011-10-31 |
Эли Лилли Энд Компани |
Триазолиламинопиримидиновые соединения
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
CN101801955B
(zh)
|
2007-07-05 |
2013-05-08 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
|
JP2010533700A
(ja)
*
|
2007-07-16 |
2010-10-28 |
アストラゼネカ アクチボラグ |
ピリミジン誘導体
|
|
EA201000296A1
(ru)
|
2007-08-14 |
2010-08-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Новые соединения
|
|
EP2025675A1
(de)
|
2007-08-14 |
2009-02-18 |
Boehringer Ingelheim International GmbH |
Arylsulfonamide mit analgetischer Wirkung
|
|
US8278313B2
(en)
|
2008-03-11 |
2012-10-02 |
Abbott Laboratories |
Macrocyclic spiro pyrimidine derivatives
|
|
EP2100894A1
(en)
|
2008-03-12 |
2009-09-16 |
4Sc Ag |
Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
|
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
CN102105150B
(zh)
|
2008-05-21 |
2014-03-12 |
阿里亚德医药股份有限公司 |
用作激酶抑制剂的磷衍生物
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
NZ624345A
(en)
|
2008-06-27 |
2016-07-29 |
Celgene Avilomics Res Inc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
BRPI0914556A2
(pt)
*
|
2008-08-12 |
2015-08-04 |
Boehringer Ingelheim Int |
Processo para a preparação de compostos de piperazina substituídos por cicloalquila
|
|
EP2161259A1
(de)
|
2008-09-03 |
2010-03-10 |
Bayer CropScience AG |
4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
|
|
AR074210A1
(es)
*
|
2008-11-24 |
2010-12-29 |
Boehringer Ingelheim Int |
Derivados de pirimidina como inhibidores de ptk2-quinasa
|
|
TW201024281A
(en)
|
2008-11-24 |
2010-07-01 |
Boehringer Ingelheim Int |
New compounds
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
US8809343B2
(en)
*
|
2008-12-26 |
2014-08-19 |
Fudan University |
Pyrimidine derivative, preparation method and use thereof
|
|
WO2010078369A2
(en)
|
2008-12-30 |
2010-07-08 |
Rigel Pharmaceuticals, Inc. |
Pyrimidinediamine kinase inhibitors
|
|
US20110071158A1
(en)
*
|
2009-03-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
New compounds
|
|
EP2421854B1
(en)
|
2009-04-24 |
2014-07-23 |
F.Hoffmann-La Roche Ag |
Inhibitors of bruton's tyrosine kinase
|
|
US9908884B2
(en)
|
2009-05-05 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
EGFR inhibitors and methods of treating disorders
|
|
JP2012527474A
(ja)
*
|
2009-05-22 |
2012-11-08 |
エクセリクシス， インク． |
増殖性疾患に対するベンゾキサゼピンベースのｐｉ３ｋ／ｍｔ０ｒ阻害剤
|
|
CN102459248A
(zh)
|
2009-05-26 |
2012-05-16 |
埃克塞里艾克西斯公司 |
作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法
|
|
TW201100441A
(en)
*
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
CN102725290B
(zh)
|
2009-07-27 |
2016-03-09 |
吉利德科学股份有限公司 |
作为离子通道调节剂的稠合杂环化合物
|
|
JP5539518B2
(ja)
|
2009-08-14 |
2014-07-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
２−アミノ−５−トリフルオロメチルピリミジン誘導体の位置選択的調製
|
|
US8933227B2
(en)
|
2009-08-14 |
2015-01-13 |
Boehringer Ingelheim International Gmbh |
Selective synthesis of functionalized pyrimidines
|
|
AU2010295690B2
(en)
|
2009-09-16 |
2016-07-28 |
Celgene Avilomics Research, Inc. |
Protein kinase conjugates and inhibitors
|
|
KR20130067487A
(ko)
|
2009-12-30 |
2013-06-25 |
아빌라 테라퓨틱스, 인크. |
단백질의 리간드-지정 공유 변형
|
|
US8927547B2
(en)
|
2010-05-21 |
2015-01-06 |
Noviga Research Ab |
Pyrimidine derivatives
|
|
MX2012014158A
(es)
|
2010-06-04 |
2013-02-07 |
Hoffmann La Roche |
Derivados de aminopirimidina como moduladores de proteina cinasa rica repeticiones leucina 2 (lrrk2).
|
|
ES2529119T3
(es)
|
2010-07-02 |
2015-02-17 |
Gilead Sciences, Inc. |
Compuestos heterocíclicos condensados como moduladores de canales iónicos
|
|
EP3144298A1
(en)
|
2010-08-10 |
2017-03-22 |
Celgene Avilomics Research, Inc. |
Besylate salt of a btk inhibitor
|
|
US9238629B2
(en)
|
2010-11-01 |
2016-01-19 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
EP2635284B1
(en)
|
2010-11-01 |
2019-12-18 |
Celgene CAR LLC |
Heterocyclic compounds and uses thereof
|
|
PH12013500880A1
(en)
|
2010-11-10 |
2013-07-01 |
Hoffmann La Roche |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators
|
|
EP2637502B1
(en)
|
2010-11-10 |
2018-01-10 |
Celgene CAR LLC |
Mutant-selective egfr inhibitors and uses thereof
|
|
EP2646448B1
(en)
|
2010-11-29 |
2017-08-30 |
OSI Pharmaceuticals, LLC |
Macrocyclic kinase inhibitors
|
|
US8546443B2
(en)
|
2010-12-21 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Benzylic oxindole pyrimidines
|
|
AU2012230229A1
(en)
|
2011-03-24 |
2013-10-10 |
Noviga Research Ab |
Novel pyrimidine derivatives
|
|
KR101884010B1
(ko)
|
2011-05-04 |
2018-07-31 |
어리어드 파마슈티칼스, 인코포레이티드 |
Egfr-유도된 암의 세포 증식을 억제하는 화합물
|
|
TWI510480B
(zh)
|
2011-05-10 |
2015-12-01 |
Gilead Sciences Inc |
充當離子通道調節劑之稠合雜環化合物
|
|
TWI549944B
(zh)
|
2011-07-01 |
2016-09-21 |
吉李德科學股份有限公司 |
作為離子通道調節劑之稠合雜環化合物
|
|
NO3175985T3
(enExample)
|
2011-07-01 |
2018-04-28 |
|
|
|
CA2853498A1
(en)
|
2011-10-28 |
2013-05-02 |
Celgene Avilomics Research, Inc. |
Methods of treating a bruton's tyrosine kinase disease or disorder
|
|
WO2013106614A1
(en)
|
2012-01-13 |
2013-07-18 |
Bristol-Myers Squibb Company |
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
|
JP6109195B2
(ja)
|
2012-01-13 |
2017-04-05 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
キナーゼ阻害剤として有用な複素環置換されたピリジル化合物
|
|
US9242976B2
(en)
|
2012-01-13 |
2016-01-26 |
Bristol-Myers Squibb Company |
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
|
CN108658873B
(zh)
|
2012-03-15 |
2021-09-14 |
西建卡尔有限责任公司 |
表皮生长因子受体激酶抑制剂的固体形式
|
|
SI2825042T1
(sl)
|
2012-03-15 |
2019-01-31 |
Celgene Car Llc |
Soli inhibitorja kinaze receptorja faktorja epidermalne rasti
|
|
US20150166591A1
(en)
|
2012-05-05 |
2015-06-18 |
Ariad Pharmaceuticals, Inc. |
Methods and compositions for raf kinase mediated diseases
|
|
ES2595222T3
(es)
*
|
2012-10-18 |
2016-12-28 |
Bayer Pharma Aktiengesellschaft |
Derivados de 5-fluoro-N-(piridin-2-il)piridin-2-amina que contienen un grupo sulfona
|
|
PE20150953A1
(es)
|
2012-11-08 |
2015-06-20 |
Bristol Myers Squibb Co |
Compuestos de piridilo sustituidos con heteroarilo utiles como moduladores de cinasa
|
|
WO2014074657A1
(en)
|
2012-11-08 |
2014-05-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
|
|
US9126950B2
(en)
|
2012-12-21 |
2015-09-08 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
EA201591051A1
(ru)
|
2013-02-08 |
2016-06-30 |
Селджен Авиломикс Рисерч, Инк. |
Ингибиторы erk и варианты их применения
|
|
JP6091248B2
(ja)
*
|
2013-02-22 |
2017-03-08 |
キヤノン株式会社 |
プリンタ
|
|
GEP201706699B
(en)
|
2013-03-14 |
2017-07-10 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
|
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
UY35935A
(es)
|
2014-01-03 |
2015-06-30 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Compuestos de nicotinamida sustituida con heteroarilo como inhibidores de quinasa y moduladores de irak-4
|
|
EP3179858B1
(en)
|
2014-08-13 |
2019-05-15 |
Celgene Car Llc |
Forms and compositions of an erk inhibitor
|
|
CN108026099B
(zh)
|
2015-06-24 |
2020-07-10 |
百时美施贵宝公司 |
经杂芳基取代的氨基吡啶化合物
|
|
KR102641263B1
(ko)
|
2015-06-24 |
2024-02-26 |
브리스톨-마이어스 스큅 컴퍼니 |
헤테로아릴 치환된 아미노피리딘 화합물
|
|
EP3313840B1
(en)
|
2015-06-24 |
2019-07-24 |
Bristol-Myers Squibb Company |
Heteroaryl substituted aminopyridine compounds
|
|
EP3328847B1
(en)
*
|
2015-07-29 |
2019-09-11 |
Esteve Pharmaceuticals, S.A. |
N-(2-(3-(benzyl(methyl)amino)pyrrolidin-1-yl)ethyl)-n-phenyl)propionamide derivatives and related compounds as dual sigma 1 and mu opioid receptor ligands for the treatment of pain
|
|
TWI724056B
(zh)
*
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
CN106831730B
(zh)
*
|
2017-01-11 |
2019-11-26 |
温州医科大学 |
一种取代的二氨基嘧啶类化合物及其在制备抗恶性肿瘤药物中的用途
|
|
TW201900640A
(zh)
|
2017-05-11 |
2019-01-01 |
美商必治妥美雅史谷比公司 |
作為irak4抑制劑之噻吩并吡啶及苯并噻吩
|
|
JP7322036B2
(ja)
|
2018-01-08 |
2023-08-07 |
ケモセントリックス，インコーポレイティド |
Ｃｃｒ６またはｃｘｃｒ２のアンタゴニストを用いて汎発性膿疱性乾癬を治療する方法
|
|
KR20220035447A
(ko)
|
2019-07-18 |
2022-03-22 |
브리스톨-마이어스 스큅 컴퍼니 |
IRAK4 억제제로서 유용한 피라졸로[3,4-d]피롤로[1,2-b]피리다지닐 화합물
|
|
WO2021011724A1
(en)
|
2019-07-18 |
2021-01-21 |
Bristol-Myers Squibb Company |
Tricyclic heteroaryl compounds useful as irak4 inhibitors
|
|
WO2021113689A1
(en)
*
|
2019-12-06 |
2021-06-10 |
Yale University |
Spak/osr inhibitors and methods of using same
|
|
JP7682191B2
(ja)
|
2020-02-03 |
2025-05-23 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｉｒａｋ４阻害剤として有用な三環ヘテロアリール化合物
|
|
WO2021158495A1
(en)
|
2020-02-03 |
2021-08-12 |
Bristol-Myers Squibb Company |
Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as irak4 inhibitors
|
|
JP2024502175A
(ja)
*
|
2021-01-07 |
2024-01-17 |
オンタリオ・インスティテュート・フォー・キャンサー・リサーチ（オーアイシーアール） |
Ｎｕａｋキナーゼの阻害剤としてのイソインドリノンアミノピリミジン化合物、その組成物及び使用
|
|
CN117658987A
(zh)
*
|
2022-09-08 |
2024-03-08 |
上海深势唯思科技有限责任公司 |
作为plk1抑制剂的化合物及其制备方法和用途
|
|
CN119285624B
(zh)
*
|
2024-09-25 |
2025-09-23 |
南方医科大学中西医结合医院 |
一种含噻吩的嘧啶类化合物及其制备方法与在制备具有抗癌作用的药物中的应用
|